Incyte Intangibles (Net) decreased by 5.9% to $110.16M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $107.61M to $110.16M. Over 5 years (FY 2020 to FY 2025), Intangibles (Net) shows a downward trend with a -7.4% CAGR.
An increase often follows strategic acquisitions or significant R&D capitalization, while a decrease may indicate amortization or impairment charges.
This represents the net book value of non-physical assets, such as patents, trademarks, software, and customer relations...
Highly relevant for healthcare and technology firms; peers often disclose the composition of these assets in financial footnotes.
intangible_assets_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $161.52M | $156.14M | $150.76M | $145.37M | $139.99M | $134.60M | $129.22M | $140.66M | $134.95M | $129.25M | $123.55M | $117.84M | $113.54M | $119.99M | $113.80M | $107.61M | $126.42M | $119.42M | $117.13M | $110.16M |
| QoQ Change | — | -3.3% | -3.4% | -3.6% | -3.7% | -3.8% | -4.0% | +8.9% | -4.1% | -4.2% | -4.4% | -4.6% | -3.7% | +5.7% | -5.2% | -5.4% | +17.5% | -5.5% | -1.9% | -5.9% |
| YoY Change | — | — | — | — | -13.3% | -13.8% | -14.3% | -3.2% | -3.6% | -4.0% | -4.4% | -16.2% | -15.9% | -7.2% | -7.9% | -8.7% | +11.3% | -0.5% | +2.9% | +2.4% |